Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ASKG315 |
Synonyms | |
Therapy Description |
ASKG315 is an IL-15 prodrug that potentially induces antitumor immune activity (Journal for ImmunoTherapy of Cancer 2022;10). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ASKG315 | ASKG-315|ASKG 315|ASKG215b|ASKG215beta|ASKG 215b | ASKG315 is an IL-15 prodrug that potentially induces antitumor immune activity (Journal for ImmunoTherapy of Cancer 2022;10). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05509985 | Phase I | ASKG315 | A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors | Not yet recruiting | AUS | 0 |